SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobert Walters Regulatory News (RWA)

Share Price Information for Robert Walters (RWA)

Share Price is delayed by 15 minutes
Get Live Data
85.00    1.00 (1.19%)
Bid:
84.00
Ask:
89.20
Spread: 5.20 (6.19%)
Market Cap: £55.91m
RWA Live PriceLast checked at - London Stock Exchange

Intraday Robert Walters Share Chart

Interim Management Statement

11 Oct 2011 07:00

RNS Number : 9220P
Robert Walters PLC
11 October 2011
Β 

ο»Ώ

11 October 2011

Β 

ROBERT WALTERS PLC

Β 

Interim management statement for the third quarter ended 30 September 2011

Β 

Β 

FINANCIAL AND OPERATIONAL HIGHLIGHTS

Β 

Gross Profit (Net Fee Income)

Q3 2011

Q3 2010

% change

% change (constant currency*)

Asia Pacific

Β£25.4m

Β£21.5m

+18%

+10%

UK

Β£12.1m

Β£12.6m

-4%

N/A

Europe

Β£9.2m

Β£7.4m

+24%

+18%

The Americas and South Africa

Β£1.3m

Β£0.9m

+44%

+44%

Group

Β£48.0m

Β£42.5m

+13%

+8%

Β 

Β·; 75% of Group's net fee income generated from international businesses.

Β·; Strong growth in France and Germany: second German office opened in Frankfurt.

Β·; Further investment in Asia, with the opening of the Group's first office in Indonesia.

Β·; UK market conditions remain challenging.

Β·; Recently opened office in Sao Paulo, the Group's first in South America, continues to perform well.

Β·; Group headcount of 2,001 (30 June 2011: 1,932).

Β·; All major office moves (London, Singapore and Sydney) successfully completed.

Β·; Balance sheet remains strong, with net cash in excess of Β£5m as at 30 September 2011 (Β£10.7m as at 30 June 2011).

Β 

Robert Walters, Chief Executive, commented:

Β 

"During the third quarter, we have increased Group net fee income and achieved strong growth across our international businesses. Net fee income growth, whilst positive, has slowed as markets have become more challenging. Group headcount increased by 4% to 2,001,Β mainly in Asia and Continental Europe andΒ year to date we have opened five offices, two in new countries. The Group is in a robust position as a result of this strategy of international growth and diversification and we continue to invest in those markets where longer term growth opportunities are strongest."

Β 

The Group will publish its fourth quarter and full year trading update on 6 January 2012.

Β 

Β * Constant currency is calculated by applying prior year exchange rates to local currency results for the current and prior years.

Β 

ENQUIRIES:Robert Walters plc

+44 (0) 20 7379 3333

Robert Walters, Chief Executive

Alan Bannatyne, Group Finance Director

Pelham Bell Pottinger

James Henderson

+44 (0) 20 7861 3160

jhenderson@pelhambellpottinger.co.uk

Archie Berens

+44 (0) 20 7861 3112

aberens@pelhambellpottinger.co.uk

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBRBDGIGBBGBG
Date   Source Headline
5th Dec 202411:49 amRNSHolding(s) in Company
3rd Dec 202411:50 amRNSHolding(s) in Company
13th Nov 20242:38 pmRNSHolding(s) in Company
13th Nov 20242:37 pmRNSHolding(s) in Company
23rd Oct 20245:21 pmRNSDirector/PDMR Shareholding
15th Oct 202410:04 amRNSBLOCK LISTING SIX MONTHLY RETURN
15th Oct 20247:00 amRNSQ3 2024 Trading Update
26th Sep 20247:00 amRNS2024 Capital Markets Event
28th Aug 20244:16 pmRNSHolding(s) in Company
12th Aug 20244:06 pmRNSHolding(s) in Company
2nd Aug 20249:47 amRNSDirector/PDMR Shareholding
1st Aug 20247:00 amRNS2024 Half-Year Results
15th Jul 20247:00 amRNSQ2 2024 Trading Update
10th Jun 20244:46 pmRNSHolding(s) in Company
15th May 20244:27 pmRNSHolding(s) in Company
15th May 20244:24 pmRNSHolding(s) in Company
30th Apr 20244:21 pmRNSResult of AGM
25th Apr 20246:30 pmRNSHolding(s) in Company
19th Apr 20241:34 pmRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSQ1 2024 Trading Update
15th Apr 20242:08 pmRNSBlock listing Interim Review
2nd Apr 20241:06 pmRNSHolding(s) in Company
28th Mar 20243:40 pmRNSTotal Voting Rights
28th Mar 20243:11 pmRNSAnnual Financial Report
28th Mar 20243:09 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSDividend Declaration
7th Mar 20247:00 amRNSFY23 results
31st Jan 20243:35 pmRNSTotal Voting Rights
11th Jan 20247:00 amRNSQ4 2023 Trading Update
10th Jan 20242:25 pmRNSHolding(s) in Company
29th Dec 20231:19 pmRNSTotal Voting Rights
14th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20233:43 pmRNSTotal Voting Rights
19th Oct 20236:00 pmRNSHolding(s) in Company
13th Oct 20232:04 pmRNSBlock Listing Six Monthly Return
10th Oct 20237:00 amRNSRESILIENT PERFORMANCE
2nd Oct 20237:30 amRNSTotal Voting Rights
2nd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20234:25 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20231:00 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20234:40 pmRNSHolding(s) in Company
7th Sep 20239:28 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.